Sfoglia per Rivista RADIOTHERAPY AND ONCOLOGY
Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison
2013-01-01 Fellin, F; Azzeroni, R; Maggio, A; Lorentini, S; Cozzarini, C; Di Muzio, N; Fiorino, C; Calandrino, R; Schwarz, M
Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison
2011-01-01 Schwarz, M; Pierelli, A; Fiorino, C; Fellin, F; Cattaneo, Gm; Cozzarini, C; Di Muzio, N; Calandrino, R; Widesott, L
Hypofractionated 4D-PET/CT-based helical tomotherapy for the treatment of lung metastases: A feasibility study
2006-01-01 Di Muzio, N; Cattaneo, Gm; Mangili, P; Tamborra, P; Schipani, S; Bettinardi, V; Landoni, C; Danna, M; Picchio, M; Calandrino, R; Fazio, F.
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study
2008-01-01 Cozzarini, C; Fiorino, C; Di Muzio, N; Valdagni, R; Salonia, Andrea; Alongi, F; Broggi, S; Guazzoni, G; Montorsi, Francesco; Rigatti, P; Calandrino, R; Fazio, F.; DI MUZIO, NADIA GISELLA
Hypofractioniated (HF) RT of locally advanced pancreatic cancer: A planning design
2006-01-01 Cattaneo, G; Passoni, P; Esposito, D; Bettinardi, B; Reni, M; Broggi, S; Tamborra, P; Di Muzio, N; Fazio, F; Calandrino, R
Hypothalamic-pitiuitary fnction in adults exposed to cranial irradiation for nonpituitary primary brain tumours: Preliminary report of one single center
2007-01-01 Motta, M; Perna, L; Losa, M; Lanzi, R; Madaschi, S; Bolognesi, A; Fiorino, C; Mazza, E; Guerra, C; Reni, M; Calandrino, R; Fazio, F
Impact of 4DCT target definition on 3DCRT and IMRT planning of locally advanced pancreatic carcinoma
2007-01-01 Sangalli, G; Passoni, P; Cattaneo, Gm; Broggi, S; Esposito, D; Bettinardi, V; Reni, M; Danna, M; Mancosu, P; Fazio, F; Calandrino, R
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy
2009-01-01 Alongi, F; Fiorino, C; Cozzarini, C; Broggi, S; Perna, L; Cattaneo, Gm; Calandrino, R; Di Muzio, N
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy
2021-01-01 Alongi, F.; Arcangeli, S.; Cuccia, F.; D'Angelillo, R. M.; Di Muzio, N. G.; Filippi, A. R.; Jereczek-Fossa, B. A.; Livi, L.; Pergolizzi, S.; Scorsetti, M.; Corvo, R.; Magrini, S. M.
In-gantry or remote patient positioning? Monte Carlo simulations for proton therapy centers of different sizes
2012-01-01 Fava, G; Widesott, L; Fellin, F; Amichetti, M; Viesi, V; Lomax, Aj; Lederer, L; Hug, Eb; Fiorino, C; Salvadori, G; Di Muzio, N; Schwarz, M
Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: evaluation and reproducibility
2010-01-01 Cattaneo, Gm; Passoni, P; Sangalli, G; Slim, N; Longobardi, B; Mancosu, P; Bettinardi, V; Di Muzio, N; Calandrino, R
Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning
1998-01-01 Fiorino, C; Reni, M; Bolognesi, A; Cattaneo, Gm; Calandrino, R
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience
2009-01-01 Valentini, V; Calvo, F; Reni, M; Krempien, R; Sedlmayer, F; Buchler, Mw; Di Carlo, V; Doglietto, Gb; Fastner, G; Garcia-Sabrido, Jl; Mattiucci, G; Morganti, Ag; Passoni, P; Roeder, F; D'Agostino, Gr
Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: Implications for the assessment of the optimal correction strategies
2009-01-01 Broggi, S; Cozzarini, C; Fiorino, C; Maggiulli, E; Alongi, F; Cattaneo, Gm; Di Muzio, N; Calandrino, R.
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study
2022-01-01 Nicosia, L.; Franceschini, D.; Perrone-Congedi, F.; Casamassima, F.; Gerardi, M. A.; Rigo, M.; Mazzola, R.; Perna, M.; Scotti, V.; Fodor, A.; Iurato, A.; Pasqualetti, F.; Gadducci, G.; Chiesa, S.; Niespolo, R. M.; Bruni, A.; Alicino, G.; Frassinelli, L.; Borghetti, P.; Di Marzo, A.; Ravasio, A.; De Bari, B.; Sepulcri, M.; Aiello, D.; Mortellaro, G.; Sangalli, C.; Franceschini, M.; Montesi, G.; Aquilanti, F. M.; Lunardi, G.; Valdagni, R.; Fazio, I.; Scarzello, G.; Corti, L.; Vavassori, V.; Maranzano, E.; Magrini, S. M.; Arcangeli, S.; Gambacorta, M. A.; Valentini, V.; Paiar, F.; Ramella, S.; Di Muzio, N. G.; Livi, L.; Jereczek-Fossa, B. A.; Osti, M. F.; Scorsetti, M.; Alongi, F.
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma
2021-01-01 Slim, N; Pacifico, P; Passoni, P; Tummineri, R; Ronzoni, M; Pedica, F; Fiorino, C; Deli, Am; Gardini, Ac; Cascinu, S; De Cobelli, F; Aldrighetti, L; DI MUZIO, NADIA GISELLA
PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool?
2010-01-01 Gregoire, V; Chiti, A
PET/CT guided helical tomotherapy in patients with locally advanced pancreatic cancer
2005-01-01 Di Muzio, N; Broggi, S; Passoni, P; Schipani, S; Molinelli, S; Picchio, M; Calandrino, R; Fazio, F.
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases
2006-01-01 Giovacchini, G; Di Muzio, N; Cattaneo, G; Messa, C; Mangili, P; Alongi, F; Picchio, M; Landoni, C; Calandrino, R; Fazio, F.
Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma
2017-01-01 Slim, N; Chiorda, Bn; Gumina, C; Cattaneo, Gm; Reni, M; Aldrighetti, L; Deli, Am; Zerbetto, F; Passoni, P; Di Muzio, N
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison | 1-gen-2013 | Fellin, F; Azzeroni, R; Maggio, A; Lorentini, S; Cozzarini, C; Di Muzio, N; Fiorino, C; Calandrino, R; Schwarz, M | |
Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison | 1-gen-2011 | Schwarz, M; Pierelli, A; Fiorino, C; Fellin, F; Cattaneo, Gm; Cozzarini, C; Di Muzio, N; Calandrino, R; Widesott, L | |
Hypofractionated 4D-PET/CT-based helical tomotherapy for the treatment of lung metastases: A feasibility study | 1-gen-2006 | Di Muzio, N; Cattaneo, Gm; Mangili, P; Tamborra, P; Schipani, S; Bettinardi, V; Landoni, C; Danna, M; Picchio, M; Calandrino, R; Fazio, F. | |
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study | 1-gen-2008 | Cozzarini, C; Fiorino, C; Di Muzio, N; Valdagni, R; Salonia, Andrea; Alongi, F; Broggi, S; Guazzoni, G; Montorsi, Francesco; Rigatti, P; Calandrino, R; Fazio, F.; DI MUZIO, NADIA GISELLA | |
Hypofractioniated (HF) RT of locally advanced pancreatic cancer: A planning design | 1-gen-2006 | Cattaneo, G; Passoni, P; Esposito, D; Bettinardi, B; Reni, M; Broggi, S; Tamborra, P; Di Muzio, N; Fazio, F; Calandrino, R | |
Hypothalamic-pitiuitary fnction in adults exposed to cranial irradiation for nonpituitary primary brain tumours: Preliminary report of one single center | 1-gen-2007 | Motta, M; Perna, L; Losa, M; Lanzi, R; Madaschi, S; Bolognesi, A; Fiorino, C; Mazza, E; Guerra, C; Reni, M; Calandrino, R; Fazio, F | |
Impact of 4DCT target definition on 3DCRT and IMRT planning of locally advanced pancreatic carcinoma | 1-gen-2007 | Sangalli, G; Passoni, P; Cattaneo, Gm; Broggi, S; Esposito, D; Bettinardi, V; Reni, M; Danna, M; Mancosu, P; Fazio, F; Calandrino, R | |
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy | 1-gen-2009 | Alongi, F; Fiorino, C; Cozzarini, C; Broggi, S; Perna, L; Cattaneo, Gm; Calandrino, R; Di Muzio, N | |
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy | 1-gen-2021 | Alongi, F.; Arcangeli, S.; Cuccia, F.; D'Angelillo, R. M.; Di Muzio, N. G.; Filippi, A. R.; Jereczek-Fossa, B. A.; Livi, L.; Pergolizzi, S.; Scorsetti, M.; Corvo, R.; Magrini, S. M. | |
In-gantry or remote patient positioning? Monte Carlo simulations for proton therapy centers of different sizes | 1-gen-2012 | Fava, G; Widesott, L; Fellin, F; Amichetti, M; Viesi, V; Lomax, Aj; Lederer, L; Hug, Eb; Fiorino, C; Salvadori, G; Di Muzio, N; Schwarz, M | |
Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: evaluation and reproducibility | 1-gen-2010 | Cattaneo, Gm; Passoni, P; Sangalli, G; Slim, N; Longobardi, B; Mancosu, P; Bettinardi, V; Di Muzio, N; Calandrino, R | |
Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning | 1-gen-1998 | Fiorino, C; Reni, M; Bolognesi, A; Cattaneo, Gm; Calandrino, R | |
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience | 1-gen-2009 | Valentini, V; Calvo, F; Reni, M; Krempien, R; Sedlmayer, F; Buchler, Mw; Di Carlo, V; Doglietto, Gb; Fastner, G; Garcia-Sabrido, Jl; Mattiucci, G; Morganti, Ag; Passoni, P; Roeder, F; D'Agostino, Gr | |
Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: Implications for the assessment of the optimal correction strategies | 1-gen-2009 | Broggi, S; Cozzarini, C; Fiorino, C; Maggiulli, E; Alongi, F; Cattaneo, Gm; Di Muzio, N; Calandrino, R. | |
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study | 1-gen-2022 | Nicosia, L.; Franceschini, D.; Perrone-Congedi, F.; Casamassima, F.; Gerardi, M. A.; Rigo, M.; Mazzola, R.; Perna, M.; Scotti, V.; Fodor, A.; Iurato, A.; Pasqualetti, F.; Gadducci, G.; Chiesa, S.; Niespolo, R. M.; Bruni, A.; Alicino, G.; Frassinelli, L.; Borghetti, P.; Di Marzo, A.; Ravasio, A.; De Bari, B.; Sepulcri, M.; Aiello, D.; Mortellaro, G.; Sangalli, C.; Franceschini, M.; Montesi, G.; Aquilanti, F. M.; Lunardi, G.; Valdagni, R.; Fazio, I.; Scarzello, G.; Corti, L.; Vavassori, V.; Maranzano, E.; Magrini, S. M.; Arcangeli, S.; Gambacorta, M. A.; Valentini, V.; Paiar, F.; Ramella, S.; Di Muzio, N. G.; Livi, L.; Jereczek-Fossa, B. A.; Osti, M. F.; Scorsetti, M.; Alongi, F. | |
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma | 1-gen-2021 | Slim, N; Pacifico, P; Passoni, P; Tummineri, R; Ronzoni, M; Pedica, F; Fiorino, C; Deli, Am; Gardini, Ac; Cascinu, S; De Cobelli, F; Aldrighetti, L; DI MUZIO, NADIA GISELLA | |
PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool? | 1-gen-2010 | Gregoire, V; Chiti, A | |
PET/CT guided helical tomotherapy in patients with locally advanced pancreatic cancer | 1-gen-2005 | Di Muzio, N; Broggi, S; Passoni, P; Schipani, S; Molinelli, S; Picchio, M; Calandrino, R; Fazio, F. | |
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases | 1-gen-2006 | Giovacchini, G; Di Muzio, N; Cattaneo, G; Messa, C; Mangili, P; Alongi, F; Picchio, M; Landoni, C; Calandrino, R; Fazio, F. | |
Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma | 1-gen-2017 | Slim, N; Chiorda, Bn; Gumina, C; Cattaneo, Gm; Reni, M; Aldrighetti, L; Deli, Am; Zerbetto, F; Passoni, P; Di Muzio, N |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile